As of 2024-07-27, the Relative Valuation of Aldeyra Therapeutics Inc (ALDX) is (13.79) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.15 USD, the upside of Aldeyra Therapeutics Inc based on Relative Valuation is -432.3%.
The range of the Relative Valuation is (7.22) - (13.93) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 14.3x - 31.4x | 30.8x |
| Forward P/E multiples | 12.6x - 27.6x | 23.8x |
| Fair Price | (7.22) - (13.93) | (13.79) |
| Upside | -274.1% - -435.8% | -432.3% |
| Date | P/E |
| 2024-07-26 | -8.21 |
| 2024-07-25 | -8.10 |
| 2024-07-24 | -7.74 |
| 2024-07-23 | -7.94 |
| 2024-07-22 | -7.66 |
| 2024-07-19 | -7.56 |
| 2024-07-18 | -7.66 |
| 2024-07-17 | -8.06 |
| 2024-07-16 | -8.51 |
| 2024-07-15 | -7.84 |
| 2024-07-12 | -7.64 |
| 2024-07-11 | -7.20 |
| 2024-07-10 | -6.73 |
| 2024-07-09 | -6.73 |
| 2024-07-08 | -6.55 |
| 2024-07-05 | -6.31 |
| 2024-07-03 | -6.33 |
| 2024-07-02 | -6.43 |
| 2024-07-01 | -6.43 |
| 2024-06-28 | -6.55 |
| 2024-06-27 | -6.73 |
| 2024-06-26 | -6.43 |
| 2024-06-25 | -6.59 |
| 2024-06-24 | -6.51 |
| 2024-06-21 | -6.89 |
| 2024-06-20 | -6.72 |
| 2024-06-18 | -7.18 |
| 2024-06-17 | -7.28 |
| 2024-06-14 | -7.38 |
| 2024-06-13 | -7.64 |
| 2024-06-12 | -7.70 |
| 2024-06-11 | -7.46 |
| 2024-06-10 | -7.66 |
| 2024-06-07 | -7.64 |
| 2024-06-06 | -7.84 |
| 2024-06-05 | -8.27 |
| 2024-06-04 | -8.10 |
| 2024-06-03 | -7.60 |
| 2024-05-31 | -7.64 |
| 2024-05-30 | -7.38 |
| 2024-05-29 | -7.32 |
| 2024-05-28 | -7.50 |
| 2024-05-24 | -7.74 |
| 2024-05-23 | -7.50 |
| 2024-05-22 | -7.66 |
| 2024-05-21 | -7.80 |
| 2024-05-20 | -7.98 |
| 2024-05-17 | -7.82 |
| 2024-05-16 | -8.10 |
| 2024-05-15 | -8.25 |